CTS Corporation Appoints Alfonso G. Zulueta as Board of Directors
April 03, 2018 at 11:47 am EDT
Share
CTS Corporation announced that Alfonso G. Zulueta, President of Lilly International and Senior Vice President of Eli Lilly and company has been appointed to its board of directors, effective April 2, 2018. Mr. Zulueta is a member of Lilly’s executive committee and is responsible for commercial operations for the company's human pharmaceutical products in all markets outside of the U.S., Canada, China and Japan. Over his 30-year career with Lilly Mr. Zulueta held key senior positions including president of global oncology and critical care products president of Asia and president of the emerging markets business unit and has contributed to both product and operational growth of the company internationally.
CTS Corporation is a global manufacturer of sensors, connectivity components, and actuators. The Company designs, manufactures, and sells a line of sensors, connectivity components, and actuators primarily to original equipment manufacturers (OEMs) and suppliers for the aerospace and defense, industrial, medical, and transportation markets. It operates manufacturing facilities in North America, Asia, and Europe. Its devices are categorized by their ability to Sense, Connect or Move. Sense products provide vital inputs to electronic systems. Connect products allow systems to function in synchronization with other systems. Move products ensure required movements are effectively and accurately executed. Its Sense products include Controls, Pedals, Piezo Sensing Products, Sensors, Switches and Transducers. Its Connect products include EMI/RFI Filters, Capacitors, Frequency Control Products, Resistors and RF filters. Its Move products include Piezo Microactuators and Rotary Actuators.
CTS CORPORATION 
